Rephrase. Regarding the study you mentioned, it suggests that increasing financial compensation could lead to more diverse clinical trial participation. This is likely because higher compensation makes participation more attractive to a wider range of individuals, including those from different socioeconomic backgrounds. This could potentially lead to more representative and inclusive clinical trials